We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$995M
AUM Growth
+$63.9M
Cap. Flow
+$40.8M
Cap. Flow %
4.1%
Top 10 Hldgs %
15.14%
Holding
1,060
New
134
Increased
450
Reduced
317
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 12.73%
2 Financials 9.55%
3 Healthcare 8.91%
4 Consumer Discretionary 8.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCN
951
DELISTED
Neovasc Inc.
NVCN
$17K ﹤0.01%
144
-360
-71% -$44.8K
IBIO icon
952
iBio
IBIO
$71M
$14K ﹤0.01%
+40
New +$16.2K
BGMS
953
Bio Green Med Solution Inc
BGMS
$5.05M
0
NVIV
954
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$12K ﹤0.01%
+22
New +$19.3K
AFH
955
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$10K ﹤0.01%
13,515
PLM
956
DELISTED
PolyMet Mining Corp.
PLM
$5K ﹤0.01%
1,150
KPRX icon
957
Kiora Pharmaceuticals
KPRX
$11.3M
$4K ﹤0.01%
3
INSY
958
DELISTED
Insys Therapeutics, Inc.
INSY
$3K ﹤0.01%
+10,500
New +$28.3K
WFT
959
DELISTED
Weatherford International plc
WFT
$3K ﹤0.01%
57,727
-30,826
-35% -$17.5K
ATNM icon
960
Actinium Pharmaceuticals
ATNM
$27M
$2K ﹤0.01%
333
AEO icon
961
American Eagle Outfitters
AEO
$2.85B
-11,154
Closed -$247K
AFMD
962
DELISTED
Affimed
AFMD
-1,100
Closed -$46K
APTV icon
963
Aptiv
APTV
$12B
-5,518
Closed -$439K
AVDL
964
DELISTED
Avadel Pharmaceuticals
AVDL
-35,535
Closed -$51K
AVXL icon
965
Anavex Life Sciences
AVXL
$222M
-14,000
Closed -$43K
BGT icon
966
BlackRock Floating Rate Income Trust
BGT
$322M
-10,600
Closed -$129K
BOE icon
967
BlackRock Enhanced Global Dividend Trust
BOE
$662M
-10,142
Closed -$109K
BOND icon
968
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.28B
-10,261
Closed -$1.08M
CAG icon
969
Conagra Brands
CAG
$7.07B
-19,721
Closed -$547K
CCL icon
970
Carnival Corporation Ltd
CCL
$36.1B
-4,328
Closed -$219K
CDTX
971
DELISTED
Cidara Therapeutics
CDTX
-803
Closed -$43K
COMT icon
972
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.19B
-20,799
Closed -$688K
CSTM icon
973
Constellium
CSTM
$3.96B
-19,000
Closed -$152K
CTMX icon
974
CytomX Therapeutics
CTMX
$705M
-18,380
Closed -$198K
CYBR
975
DELISTED
CyberArk
CYBR
-1,794
Closed -$214K

Similar funds

Wedbush Securities's Q2 2019 Portfolio in Review

As of Q2 2019, Wedbush Securities held 1,060 positions worth $995M, up 6.9% from $931M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Wedbush Securities deployed $40.8M of net new capital in Q2 2019, opening 134 new positions and adding to 450 existing holdings. Its largest new stake was Pacer WealthShield ETF: 48,221 shares worth $1.17M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was PAR Technology, an estimated $1.67M trimmed.

  • Wedbush Securities's largest Q2 2019 buy was Pacer WealthShield ETF: 48,221 shares worth $1.17M.
  • Wedbush Securities added most to Walt Disney in Q2 2019, an estimated $1.72M increase.
  • Wedbush Securities's biggest Q2 2019 reduction was PAR Technology, cutting an estimated $1.67M.
  • Wedbush Securities fully exited PIMCO Active Bond Exchange-Traded Fund in Q2 2019, selling an estimated $1.08M.
  • Wedbush Securities's ten largest holdings make up 15% of its $995M portfolio in Q2 2019.
  • Wedbush Securities opened 134 new positions and closed 75 in Q2 2019.
  • Wedbush Securities's portfolio value rose 6.9% quarter-over-quarter to $995M.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.